Patisiran Treatment in Transthyretin Cardiac Amyloidosis Quiz

Age of 25 to 80 years, diagnosis of ATTR cardiac amyloidosis, evidence of joint involvement, and history of neurological disorders

Age of 20 to 90 years, diagnosis of ATTR cardiac amyloidosis, evidence of renal involvement, and history of lung disease

Age of 18 to 85 years, diagnosis of AL amyloidosis, evidence of cardiac involvement, and history of liver disease

Age of 18 to 85 years, diagnosis of ATTR cardiac amyloidosis, evidence of cardiac involvement, and history of heart failure (correct)

Provided editorial assistance (correct)

Funded the trial

Interpreted the trial data

Conducted data analysis

All the authors who had access to the data (correct)

The sponsor

The trial investigators

Adelphi Communications

<p>New York Heart Association (NYHA) class of III and an ATTR amyloidosis stage of 3</p> Signup and view all the answers

<p>Some patients were receiving tafamidis, and others were not receiving it</p> Signup and view all the answers